A carregar...
The cost and value of cancer drugs – are new innovations outpacing our ability to pay?
Cancer drug expenditures have been increasing significantly in countries around the world. A recent paper in the IJHPR provides new knowledge and insights into this global phenomenon by analyzing how it is playing out in an Israeli health plan with over two million members, whose state-of-the-art in...
Na minha lista:
| Publicado no: | Isr J Health Policy Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5032240/ https://ncbi.nlm.nih.gov/pubmed/27688873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13584-016-0097-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|